CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
58.25
25-11月-24 09:36:51
15 分の遅延
株式
+0.71
+1.23%
本日の幅
57.50 - 58.50
ISIN
N/A
ソース
NASDAQ
-
17 9 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
William Guyer to join Corcept as Chief Development Officer
12 8 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
29 7 2021 15:05:03 提供 Nasdaq GlobeNewswire
-
12 7 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
22 6 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
15 6 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
10 6 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
06 5 2021 15:10:00 提供 Nasdaq GlobeNewswire
-
06 5 2021 15:01:01 提供 Nasdaq GlobeNewswire
-
29 4 2021 15:05:01 提供 Nasdaq GlobeNewswire
-
15 3 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
01 3 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results
23 2 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
08 2 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
01 2 2021 15:05:00 提供 Nasdaq GlobeNewswire